| Primary |
| Product Used For Unknown Indication |
32.1% |
| Prolactinoma |
32.1% |
| Catatonia |
3.6% |
| Neuroleptic Malignant Syndrome |
3.6% |
| Suppressed Lactation |
3.6% |
| Antibiotic Prophylaxis |
2.4% |
| Blood Glucose Abnormal |
2.4% |
| Breast Enlargement |
2.4% |
| Grand Mal Convulsion |
2.4% |
| Lipids Abnormal |
2.4% |
| Pituitary Tumour Benign |
2.4% |
| Anxiety Disorder |
1.2% |
| Atrophy |
1.2% |
| General Anaesthesia |
1.2% |
| Hyperprolactinaemia |
1.2% |
| Infection |
1.2% |
| Lactation Disorder |
1.2% |
| Lactation Inhibition Therapy |
1.2% |
| Menstruation Irregular |
1.2% |
| Tremor |
1.2% |
|
| Neutropenia |
8.6% |
| Completed Suicide |
5.7% |
| Hepatic Lesion |
5.7% |
| Insulin-like Growth Factor Increased |
5.7% |
| Personality Disorder |
5.7% |
| Product Quality Issue |
5.7% |
| Psychotic Disorder |
5.7% |
| Skin Irritation |
5.7% |
| Syncope |
5.7% |
| Torsade De Pointes |
5.7% |
| Transient Ischaemic Attack |
5.7% |
| Tricuspid Valve Sclerosis |
5.7% |
| Visual Acuity Reduced |
5.7% |
| Visual Impairment |
5.7% |
| Bone Erosion |
2.9% |
| Brain Stem Syndrome |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Condition Aggravated |
2.9% |
| Drug Interaction |
2.9% |
| Drug Intolerance |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
17.7% |
| Prolactinoma |
17.7% |
| Parkinson's Disease |
9.5% |
| Hypertension |
8.2% |
| Hyperlipidaemia |
5.4% |
| Restless Legs Syndrome |
5.4% |
| Suicide Attempt |
3.4% |
| Bipolar I Disorder |
2.7% |
| Constipation |
2.7% |
| Convulsion |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Grand Mal Convulsion |
2.7% |
| Hormone Level Abnormal |
2.7% |
| Hypothyroidism |
2.7% |
| Pituitary Tumour Benign |
2.7% |
| Psychotic Disorder |
2.7% |
| Drug Use For Unknown Indication |
2.0% |
| Fertility Increased |
2.0% |
| Hiv Infection |
2.0% |
| Supplementation Therapy |
2.0% |
|
| Product Quality Issue |
15.0% |
| Completed Suicide |
7.5% |
| Drug Interaction |
7.5% |
| Polyhydramnios |
7.5% |
| Psychotic Disorder |
7.5% |
| Tremor |
7.5% |
| Cerebrospinal Fluid Rhinorrhoea |
5.0% |
| Nausea |
5.0% |
| Pathological Gambling |
5.0% |
| Toxicity To Various Agents |
5.0% |
| Vomiting |
5.0% |
| Death |
2.5% |
| Dopamine Dysregulation Syndrome |
2.5% |
| Drug Abuse |
2.5% |
| Galactorrhoea |
2.5% |
| Neuroleptic Malignant Syndrome |
2.5% |
| Neutropenia |
2.5% |
| Normal Newborn |
2.5% |
| Pemphigus |
2.5% |
| Personality Disorder |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.4% |
| Drug Use For Unknown Indication |
9.6% |
| Hypertension |
5.4% |
| Mental Disorder |
5.4% |
| Primary Hypothyroidism |
4.2% |
| Cardiac Disorder |
3.7% |
| Bipolar Disorder |
3.2% |
| Blood Follicle Stimulating Hormone Decreased |
3.1% |
| Blood Luteinising Hormone Decreased |
3.1% |
| Hypogonadism Male |
2.8% |
| Parkinsonism |
2.8% |
| Blood Thyroid Stimulating Hormone Decreased |
2.6% |
| Vitamin Supplementation |
2.6% |
| Prolactinoma |
2.2% |
| Hyperlipidaemia |
2.0% |
| Acth Decreased |
1.8% |
| Multiple Sclerosis |
1.8% |
| Neuroleptic Malignant Syndrome |
1.8% |
| Pituitary Tumour |
1.8% |
| Acromegaly |
1.7% |
|
| Death |
17.6% |
| Pulmonary Embolism |
9.9% |
| Vomiting |
8.8% |
| Somatic Delusion |
7.7% |
| Paranoia |
6.6% |
| Tachycardia |
6.6% |
| Adrenal Insufficiency |
4.4% |
| Loss Of Consciousness |
4.4% |
| Oedema Peripheral |
4.4% |
| Vitamin D Decreased |
4.4% |
| Pneumonia |
3.3% |
| Sinusitis |
3.3% |
| Visual Impairment |
3.3% |
| Arthropathy |
2.2% |
| Device Expulsion |
2.2% |
| Haemorrhage |
2.2% |
| Joint Swelling |
2.2% |
| Myocardial Infarction |
2.2% |
| Neuroleptic Malignant Syndrome |
2.2% |
| Pain |
2.2% |
|
| Interacting |
| Hypertension |
16.7% |
| Hyperlipidaemia |
11.1% |
| Convulsion |
9.7% |
| Drug Use For Unknown Indication |
6.9% |
| Constipation |
5.6% |
| Gastrooesophageal Reflux Disease |
5.6% |
| Hypothyroidism |
5.6% |
| Psychotic Disorder |
5.6% |
| Type 2 Diabetes Mellitus |
5.6% |
| Adverse Event |
4.2% |
| Hiv Infection |
4.2% |
| Prolactinoma |
4.2% |
| Prophylaxis |
4.2% |
| Suppressed Lactation |
2.8% |
| Adverse Drug Reaction |
1.4% |
| Calcium Deficiency |
1.4% |
| Cardiovascular Event Prophylaxis |
1.4% |
| Grand Mal Convulsion |
1.4% |
| Hyperglycaemia |
1.4% |
| Hypovitaminosis |
1.4% |
|
| Tremor |
36.4% |
| Prolactinoma |
27.3% |
| Exposure During Pregnancy |
9.1% |
| Feeling Abnormal |
9.1% |
| Loss Of Consciousness |
9.1% |
| Vomiting |
9.1% |
|
